I studier med rekombinant faktor VIII- preparat har utveckling av inhibitorer framför allt observerats hos tidigare obehandlade hemofilipatienter. ###>In studies with recombinant factor VIII preparations, development of inhibitors is predominantly observed in previously untreated haemophiliacs.